The effects of continuous venovenous hemofiltration on coagulation activation

Table 1 Patient characteristics

Patient number	Age (years)	Gender	Diagnosis	APACHE II score^a	Cause of acute renal failure	Type of acute renal failure	Urea^b (mmol/l)	Creatinine^b (μmol/l)	Duration of the CVVH circuit studied (hours)	Filter lifespan (hours)	Outcome
Group A
1	44	Male	Subarachnoidal hemorrhage	29	Nonseptic	Anuric	21.8	432	3	4.3	Died
2	52	Male	Lung cancer and pneumonia	10	Septic	Oliguric	35	148	1	1.0	Died
8	68	Female	Thoracic aortic prosthesis	15	Nonseptic	Nonoliguric	37	415	6	22.5	Survived
9	64	Male	Ruptured abdominal aortic aneurysm	14	Nonseptic	Nonoliguric	46	379	1	1.5	Survived
Group B
3	65	Male	Ruptured abdominal aortic aneurysm	28	Nonseptic	Anuric	14.2	210	6	10.5	Survived
4	48	Male	Streptococcal sepsis	23	Septic	Oliguric	19.3	367	6	7.7	Survived
5	75	Male	Myocardial infarction	23	Nonseptic	Anuric	11.1	259	6	11.7	Died
6	65	Male	Bowel ischemia	18	Septic	Oliguric	33.8	368	6	7.0	Died
7	67	Male	Non-Hodgkin lymphoma	24	Nonseptic	Nonoliguric	44.8	392	6	31.0	Died
10	75	Male	Peritonitis	23	Septic	Oliguric	23.9	177	3	4.8	Died

Group A, patients with increased thrombin generation; group B, patients without increased thrombin generation. ^aAPACHE II score, acute physiology and chronic health evaluation II score at intensive care unit admission [26]. ^bBefore continuous venovenous hemofiltration (CVVH).

ISSN: 1364-8535